Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter:
“Happy to share our work in JCO Precision Oncology on real-world OS (overall survival) and treatment patterns by PTEN status in metastatic Castration-Sensitive Prostate Cancer (CSPC) using Flatiron Health. PTEN Loss of Function assessment with significantly reduced OS vs intact PTEN regardless of 1L treatment.”
Read further.
Source: Shilpa Gupta/X